RGMB and graft versus host disease: Treatment with 9D1 but not 2E11 RGMb mAb significantly reduced GvHD scores and improved survival (Figure 4), suggesting that RGMb blockade-mediated protection from xenograft GvHD is dependent on mouse epithelium or antigen presenting cells in the recipient.